TickerFacts.

ENDRA Life Sciences Inc. (NDRA): Capital Expenditures

Annual figures by period end, from SEC filings.

$17.3K
Year ended 2025-12-31
$18.7K
Trailing 12 months to 2026-06-30
-56.0%
3-year compound annual growth
-25.5%
5-year compound annual growth
$202.6K2017-12-31: $7.9K2018-12-31: $100.0K2019-12-31: $43.6K2020-12-31: $75.3K2021-12-31: $45.0K2022-12-31: $202.6K2023-12-31: $33.9K2024-12-31: $16.0K2025-12-31: $17.3K$17.3K
2017-12-31 Capital Expenditures (USD) 2025-12-31
Period endedCapital ExpendituresChange YoYSource filing
2025-12-31$17.3K+8.0%2026-03-31, From 2025-01-01
2024-12-31$16.0K-52.8%2026-03-31, From 2024-01-01
2023-12-31$33.9K-83.3%2025-04-07, From 2023-01-01
2022-12-31$202.6K+350.2%2024-03-28, From 2022-01-01
2021-12-31$45.0K-40.3%2023-03-16, From 2021-01-01
2020-12-31$75.3K+72.8%2022-03-30, From 2020-01-01
2019-12-31$43.6K-56.4%2021-03-25, From 2019-01-01
2018-12-31$100.0Kn/m2020-03-26, From 2018-01-01
2017-12-31$7.9Kn/a2019-03-11, From 2017-01-01

Capital Expenditures at similar companies

Companies with the same SEC industry code (Electromedical & Electrotherapeutic Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCapital ExpendituresChange YoY
ENDRA Life Sciences Inc. (NDRA)2025-12-31$17.3K+8.0%
Escalon Medical Corp (ESMC)2025-06-30$3.9K-90.4%
Nuwellis, Inc. (NUWE)2025-12-31$90.0K+50.0%
Neuraxis, Inc (NRXS)2025-12-31$31.1K+12.1%
iTonic Holdings Ltd (ITOC)2025-12-31$3.8K+342.0%
Guided Therapeutics Inc (GTHP)2025-12-31$2.0Kn/a
CapsoVision, Inc (CV)2025-12-31$90.0K-41.2%
electroCore, Inc. (ECOR)2025-12-31$66.0Kn/a
Precision Optics Corporation, Inc. (POCI)2025-06-30$227.2K-16.6%

Compare NDRA, ESMC, NUWE, NRXS side by side · Screen every company in Electromedical & Electrotherapeutic Apparatus ↗